Therapeutic Study of Prostatitis With Elevated PSA
Prostatitis, PSA
About this trial
This is an interventional treatment trial for Prostatitis
Eligibility Criteria
Inclusion Criteria: Compliant with the diagnostic criteria of both Chinese and western medicine for prostatitis; Serum PSA increases, ranging from 4 ng/mL to 10 ng/mL; Male, aged between 18 and 80 years old: B-ultrasound and imaging examination fail to consider the front row cancer; I have not taken any Chinese or western medicine for the treatment of prostatitis in the past two weeks; Those who have signed the informed consent form. Exclusion Criteria: Patients with frequent micturition caused by combined sexually transmitted diseases and urinary tract infection; oliguria or anuria caused by urinary calculi, prostate cancer, and acute and chronic renal failure; Dysuria caused by neurogenic bladder collapse, bladder neck collapse fibrosis, and urethral stricture; the residual urine volume > 150ml: Losers of invasive treatment of benign prostatic obstruction; Patients with pelvic surgery or injury history that affected the local internal organs, muscles, nerves and other functional states; B-ultrasound shows obvious bladder diverticulum or upper urinary tract obstruction caused by BPH, with impaired renal function; Patients with severe primary diseases such as cardiovascular and cerebrovascular diseases, liver and hematopoietic system, refractory diabetes mellitus, or diabetic neuropathy and psychosis; Patients with serum t-PSA>10ng/ml.
Sites / Locations
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Conventional treatment group
Conventional treatment group combined with Huange capsule
Routine treatment protocol are used base on clinical guidelines
Based on the clinical guidelines, the routine treatment was used in addition to Huange Capsule.